Can the USA boost its manufacturing capacity for critical drugs?

Pfizer is supporting homelearners amid the COVID-19 pandemic.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.

How has the COVID-19 pandemic changed the industry? And how can we respond faster next time?

Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.

How can we reduce AI's energy consumption for improved drug discovery?

A new vaccine protects against type 1 diabetes in animal models.

The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.

The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs. How can delays be avoided?